Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Aurinia Pharmaceuticals Inc.

Aurinia Pharmaceuticals Inc. (AUPH) Stock Overview

Explore Aurinia Pharmaceuticals Inc.’s financial performance, market position, analyst ratings, and future outlook.

AUPH●NASDAQ
HealthcareBiotechnology
$16.90
$0.06(0.35%)
U.S. Market opens in 21h 47m

Aurinia Pharmaceuticals Inc. (AUPH)

Meyka AI Score

Z

Key Financials

Market Cap2.2B
P/E Ratio7.20
EPS (TTM)$1.02
ROE0.59%
Fundamental Analysis

AI Price Forecasts

1 Month$14.68
3 Months$18.23
1 Year Target$20.24

AUPH Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, Aurinia Pharmaceuticals Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of AUPH on the NASDAQ shows an RSI of 60.68, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $20.24 for the NASDAQ listing.

Key metrics behind Aurinia Pharmaceuticals Inc.'s NASDAQ-traded stock include a P/E ratio of 7.20 and a market capitalization of 2.2B. Combined with our AI analysis, these give both institutional and retail investors a clear view of AUPH on the NASDAQ.

Price Performance (NASDAQ: AUPH)

1-Day Change
-0.35%
5-Day Change
3.81%
1-Month Change
10.46%
3-Month Change
2.67%
6-Month Change
20.03%
Year-to-Date (YTD) Change
5.96%
1-Year Change
31.11%
3-Year Change
101.19%
5-Year Change
-19.18%
All-Time (Max) Change
333.33%

Contact Information

https://www.auriniapharma.com
12507084272
#140, 14315 – 118 Avenue, Edmonton, AB, T5L 4S6

Company Facts

1,280 Employees
IPO DateSep 3, 2014
CountryCA
Actively Trading

Frequently Asked Questions